Qube Research & Technologies (QRT)
IRD

Qube Research & Technologies (QRT)’s Opus Genetics IRD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,978
Closed -$80.4K – 4250
2025
Q4 		$80.4K Buy
+39,978
New +$81.2K ﹤0.01% 3220

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IRD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Opus Genetics (IRD) in Q1 2026, closing a stake of 39,978 shares — an estimated $80.4K sold.

Qube Research & Technologies (QRT) first reported a position in IRD in Q4 2025 and held it in 1 quarter. The position peaked at $80.4K in Q4 2025. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Opus Genetics position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 39,978 Opus Genetics shares in Q1 2026, an estimated $80.4K.
  • Qube Research & Technologies (QRT) first reported a position in Opus Genetics in Q4 2025 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Opus Genetics position peaked at $80.4K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.